GRCL
Gracell Biotechnologies Inc.
485.20$
-2.8%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Cash Flow
All figures in millions of CNY.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 17 | Q1 18 | Q2 18 | Q4 18 | Q1 19 | Q2 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15 | -15 | -15 | -34 | -34 | -34 | -33 | -64 | -64 | – | -64 | -64 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.7 | 0.7 | 0.7 | 1.3 | 1.3 | 1.3 | 1.3 | 9.4 | 9.4 | – | 9.4 | 9.4 | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -0.4 | 0.7 | 0.7 | – | 0.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| -1.0 | -1.0 | -1.0 | 0.2 | 0.2 | 0.2 | 9.1 | – | – | – | 9.6 | 9.6 | – | – | – | – | – | – | – | – | – | – | – | |
| 2.8 | 2.8 | 2.8 | 14 | 14 | 14 | 10 | 14 | 14 | 0.0 | 14 | 14 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | – | -1.4 | -12 | -12 | – | -12 | -12 | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -11 | -11 | -11 | 0.0 | – | – | – | 0.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 38 | 38 | 38 | – | 38 | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | 693 | 693 | 693 | – | 693 | 693 | – | – | – | – | – | – | – | – | – | – | – | |
| -9.1 | -9.1 | -9.1 | 75 | 75 | 75 | -38 | 598 | 598 | – | 598 | 598 | – | – | – | – | – | -196 | – | -164 | -161 | 486 | – | |
| -18 | -18 | -18 | -48 | -48 | -48 | -43 | – | – | – | -78 | -78 | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.